• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Cerebral Venous Infarct After Recovery From COVID-19 Pneumonia

tetano

Editor, Senior Moderator
Cureus


. 2021 Nov 20;13(11):e19763.
doi: 10.7759/cureus.19763. eCollection 2021 Nov.
Cerebral Venous Infarct After Recovery From COVID-19 Pneumonia


Mohanned F Alfahhad[SUP] 1 [/SUP], Saeed S Alghamdi[SUP] 2 [/SUP], Osama A Alzahrani[SUP] 2 [/SUP], Saleh K Aldakhil[SUP] 3 [/SUP], Abdulaziz A Algarni[SUP] 3 [/SUP], Ismail A Juraybi[SUP] 4 [/SUP], Thekra M Alsalmi[SUP] 5 [/SUP], Amjad S Alsulaihebi[SUP] 6 [/SUP], Mawaddah K Yousef[SUP] 1 [/SUP], Abdulaziz S Almuhaisen[SUP] 7 [/SUP], Hamoud M Alfawzan[SUP] 8 [/SUP], Fatema M Alsalehi[SUP] 9 [/SUP], Raghad N Alsaeed[SUP] 10 [/SUP], Hareth H Alharthi[SUP] 6 [/SUP], Faisal Al-Hawaj[SUP] 11 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) may have multisystem organ involvement. Thrombotic events are well-recognized complications of COVID-19. Such complications may include the pulmonary, renal, and other organs vasculature. The risk of coagulopathy is usually related to the severity of COVID-19 pneumonia. Few cases suggested that the coagulopathy risk may persist for some period after the recovery from COVID-19. We report the case of a middle-aged man with severe COVID-19 pneumonia that required seven days of endotracheal intubation and mechanical ventilation who presented with headache and left-sided weakness that occurred three days after his discharge. A computed tomography scan was performed to rule out intracranial hemorrhage before initiating the thrombolytic therapy. The scan demonstrated hemorrhage in the right temporal lobe with surrounding vasogenic edema along with density in the right transverse sinus. Subsequently, computed tomography venography was performed and demonstrated the filling defect representing right sigmoid venous sinus thrombosis. The patient received conservative measures in the form of intravenous hydration, anticoagulation, analgesics, and anticonvulsants. During the hospital stay, the patient had improvement in his symptom and mild neurological deficit persisted. The case highlighted that risk of thrombotic complications in COVID-19 pneumonia may persist for some period after the recovery from the disease. Hence, thromboprophylaxis may be indicated in selected patients with a risk of thrombotic events after their recovery from severe COVID-19.

Keywords: case report; cerebral venous sinus thrombosis (cvst); computed tomography; coronavirus disease 2019 (covid-19); headache.
 
Back
Top Bottom